Criteria for the application of the platform approach for mRNA vaccines and gene therapy products in regulatory practice
It was found that the regulatory documentation of the Russian Federation and the EAEU lacks criteria for applying the platform approach to mRNA vaccines and gene therapy products, which hinders the accelerated introduction of innovative personalized medicinal products into clinical practice.
N. S. Pokrovsky, E. Melnikova, V. Merkulov
· Biological Products. Prevent... · 0 citations